Skip to main content
Premium Trial:

Request an Annual Quote

Ayoxxa Raises $3.4M to Develop Protein Bead Array Platform

NEW YORK (GenomeWeb News) – Ayoxxa Biosystems announced today that it has netted €2.6 million ($3.4 million) in a Series A financing round.

The Cologne, Germany-based firm said it will use the proceeds to further develop and scale-up production of in situ encoded bead-based arrays that allow the simultaneous measurement of multiple proteins from small amounts of sample material.

CEO Andreas Schmidt said in a statement that the funding provides Ayoxxa with the resources to "significantly accelerate the scale-up of production" of its arrays ahead of commercialization.

Ayoxxa was founded as a spin-off of the National University of Singapore in 2010 and established its headquarters in Cologne earlier this year. The firm maintains an office in Singapore.

Its Series A investors included Wellington Partners Venture Capital, NRW.BANK, HTGF - High-Tech-Gründerfonds, as well as private investors Rainer Christine and Gregor Siebenkotten, both formerly executive board members and co-founders of Amaxa Biosystems.

Following the fundraising, Ayoxxa's board of directors consists of Chairman Rainer Christine; board members Regina Hodits and Matthias Dill from Wellington Partners, and Aristotelis Nastos from NRW.BANK; and board observers Lukas Günther from Wellington Partners and Florian Stinauer from NRW.BANK.

Hodits said in a statement that Ayoxxa's arrays have the potential to become the "new standard" for the analysis of multiple protein-protein interactions in limited sample volumes. She said that Ayoxxa will address a research market worth "hundreds of millions of dollars" and over the longer term will "reach into pharmaceutical screening and ultimately diagnostics."

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.